US EditionPublished • loading... • Updated
Insilico Medicine nominates AI-driven drug candidate for cancer, Cushing's syndrome and obesity
Summary by News Medical
1 Articles
1 Articles
Insilico Medicine nominates AI-driven drug candidate for cancer, Cushing's syndrome and obesity
The NR3C1 (nuclear receptor subfamily 3 group C member 1) gene encodes the glucocorticoid receptor (GR), a nuclear receptor vital for maintaining physiological homeostasis, and inhibition of NR3C1 could increase the sensitivity of cancer cells to standard chemotherapy, particularly in ovarian cancer.
·United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
